The Targeting of WNT5B and WNT10B in Osteosarcoma

The Targeting of WNT5B and WNT10B in Osteosarcoma

“As there is controversy over whether we should use WNT activators or WNT inhibitors to treat osteosarcoma, we hypothesize that it depends on whether the canonical or non-canonical pathways are… read more